Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

The Struggles Of Gilead Sciences
Yahoo/Benzinga
Wed, 12/31/14 - 05:13 pm
Tags:
Gilead Sciences
Gilead Sciences, Inc. Can't Do It Alone
Motley Fool
Mon, 12/29/14 - 09:10 pm
Tags:
Gilead Sciences, HIV, JNJ
Gilead and Janssen expand partnership in HIV
Seeking Alpha
Mon, 12/29/14 - 10:55 am
Tags:
Gilead Sciences, Janssen, HIV, tenofovir, rilpivirine, emtricitabine
Does the AbbVie-Express Scripts pact signal drug-price Armageddon?
Fierce Pharma
Fri, 12/26/14 - 10:12 am
Tags:
AbbVie, Gilead Sciences, Express Scripts, drug pricing, hepatitis C
Year in review: The biggest stories in biotech in 2014
Bizjournals.com
Fri, 12/26/14 - 09:51 am
Tags:
biotech, Merck, M&A, Cubist Pharmaceuticals, Idenix, Covidien, Medtronic, Gilead Sciences, Shire, AbbVie, drug pricing
Biotech Stocks: What Could Spoil The Rally In 2015?
Forbes
Wed, 12/24/14 - 04:47 pm
Tags:
biotech, Gilead Sciences, AbbVie
Gilead Sciences (GILD) Is Hurting, And So Is The Rest Of The Biotech Sector
Bidness Etc.
Wed, 12/24/14 - 09:38 am
Tags:
Gilead Sciences, biotech, AbbVie, Amgen, Express Scripts
Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying
TheStreet.com
Tue, 12/23/14 - 04:21 pm
Tags:
Gilead Sciences, hepatitis C, AbbVie, Viekira Pak, Express Scripts
Special Sale Price: Docs Divided Over Discount on AbbVie Hepatitis C Drug
WSJ Pharmalot
Tue, 12/23/14 - 09:37 am
Tags:
physicians, AbbVie, Gilead Sciences, Viekira Pak, Express Scripts, hepatitis C
Fight over $1,100 hepatitis C pills awaits next move by CVS
San Jose Mercury News, CA
Tue, 12/23/14 - 09:34 am
Tags:
hepatitis C, Gilead Sciences, AbbVie, Viekira Pak, CVS, Express Scripts
Gilead sees largest one-day drop since IPO
Marketwatch
Tue, 12/23/14 - 09:14 am
Tags:
Gilead Sciences, hepatitis C, AbbVie, Viekira Pak, Express Scripts
The Hepatitis C Price Wars Begin: What the Express Scripts Move Means
WSJ Pharmalot
Mon, 12/22/14 - 01:06 pm
Tags:
hepatitis C, Express Scripts, AbbVie, Viekira Pak, Gilead Sciences
Gilead strikes cancer drug deal
San Francisco Chronicle, CA
Sat, 12/20/14 - 10:44 am
Tags:
Gilead Sciences, Ono Pharmaceuticals, Ono-4059
Gilead is Accused of Price Gouging, but is There Really a Legal Argument?
WSJ Pharmalot
Fri, 12/19/14 - 10:56 am
Tags:
Gilead Sciences, Harvoni, drug pricing, Sovaldi
AbbVie: Here’s How It Could Differentiate Itself From Gilead
Barron's
Thu, 12/18/14 - 04:04 pm
Tags:
AbbVie, Gilead Sciences, hepatitis C, drug pricing
More CEO watchers put Gilead's Martin on their 'best of 2014' lists
Fierce Pharma Marketing
Wed, 12/17/14 - 10:10 pm
Tags:
Gilead Sciences, John Martin
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
TheStreet.com
Wed, 12/17/14 - 10:02 am
Tags:
Biogen Idec, Bluebird Bio, Arrowhead Research, Vertex Pharmaceuticals, Cempra, CTI BioPharma, Gilead Sciences, Merck, Bristol-Myers Squibb, Sarepta Therapeutics, Neurocrine Biosciences
Gilead Sciences: What Its New Hire Means for Its Cancer Pipeline
Barron's
Mon, 12/15/14 - 03:29 pm
Tags:
Gilead Sciences, cancer, R&D, oncology
Could the World's Top-Selling Drug Be Toppled?
Motley Fool
Mon, 12/15/14 - 09:03 am
Tags:
AbbVie, Humira, Cadila, biosimilars, Sovaldi, Harvoni, Gilead Sciences
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Sat, 12/13/14 - 11:29 am
Tags:
Gilead Sciences, AbbVie, hepatitis, hepatitis C

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.